German pricing rules hit Eisai’s Halaven
Drug has “no additional benefit” in metastatic liposarcoma, says IQWiG.
X
German pricing rules hit Eisai’s Halaven
https://pharmaphorum.com/news/german-pricing-rules-hit-eisais-halaven/
Drug has “no additional benefit” in metastatic liposarcoma, says IQWiG.